Introduction
Congenital heart diseases (CHDs) are the malformation of the heart or the large blood vessels associated with the heart, affecting various parts or function. It is one of the leading causes of mortality in the first year of life. [1] [2] [3] CHDs are the common single group of abnormalities accounting for about 30% of the total congenital abnormalities. [1] It has been estimated that some types of CHDs can be related to the defects in the chromosome, gene or environmental factors. [4] In ~90% of the CHD cases, there is no identifiable cause that can be attributed as multifactorial defects. The majority of these structural abnormalities occur as isolated malformation in most patients, but about 33%
have associated anomalies. [5] According to the Merck Manual of Diagnosis Prevalence studies on CHDs have been done several times world wide. Although it is a common disease, a few studies on the prevalence of CHDs in India have been reported, of which, prevalence of CHDs in Chandigarh (5%), Punjab (3%) and South India (2.5%) are higher than other parts of the world. [7] [8] [9] In view of this, we report the prevalence of CHDs for 5 years among the patients in different hospitals of Mysore.
Materials and Methods
The present investigation was conducted in Mysore Table 1 ]. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [ Table 2] shows the prevalence of CHDs in India. [7] [8] [9] [25] [26] [27] [28] [29] [30] Studies in Chandigarh showed the maximum prevalence of 50.89 per 1000 live births [9] whereas studies in Shimla showed the minimum of 2.25 per 1000 live births.
[29] Table 3 presents the prevalence of different types of CHDs world wide in which VSD is found to be the most prevalent type of defect. [8, [20] [21] [22] [23] [24] [31] [32] [33] [34] The The other frequent defects were found to be ASD (114 patients) with a prevalence of 19.06% followed by TOF with 13.38% (80 patients) and PDA with 9.53% (57 [10] 1975 6.6 UK [11] 1981 5.51 USA [12] 1990 6.60 Bohemia [13] 1999 6.16
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New Delhi [26] Figure 2 ]. Table 5 reveals the age when the CHDs were detected in the patients. It is clear that the maximum CHDs were detected in the first year of life when compared to the later years of life [ Figure 3 ].
Discussion
The recent exponential increase in the knowledge of genetics has revolutionized the understanding of CHDs during the past few decades. [35] India alone has one sixth share of the world population, which is a suitable place to generate meaningful data on the prevalence of CHDs. 1 m = neonates to one month of age; 6 m = The age of the children is more than one month and less than six months; 1 y = The age of the children is more than six months and less than one year; 2 y= The age of the children is more than one year and less than two year; and so on.
Therefore the present work has been undertaken to other Indian studies. [28, [31] [32] This could be due to the severity of the defects which might have lead to the death of the patients before accessing the medical facilities.
This might also be due to racial and genetic factors in different populations. Of the total CHDs a few cases which were clinically diagnosed as CHDs could not be which is accessible to the common man.
